Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer7 Nov 2026

1061 Anchored immunotherapy with CD137 (4-1BB) and CD122 (IL-2/15Rβ) multi-agonists induce monotherapy anti-tumor immunity and abscopal responses without systemic toxicity

Kanika Jain¹
Sailaja Battula²
Robert G Newman³
Howard L Kaufman³

¹Deptt. of Hospital Administration, All India Institute of Medical Sciences (AIIMS) New Delhi India
²Ankyra Therapeutics, Inc., Cambridge, MA, USA
³Ankyra Therapeutics, Cambridge, MA, USA

Spatially tuned localization of interleukins and OX40 agonists enhances synergistic anti-tumor immunity
John H. Klich, Anahita Nejatfard, Emily L. Meany +4
Cell Reports Medicine9 Oct 2026Peer-reviewedCC BY-NC 4.0Full textOncologyPMC
Editorial: Community series in unveiling the next generation of cancer immunity & immunotherapy in lung cancer, volume II
Nethaji Muniraj, Mohanraj Sadasivam, Chellappagounder Thangavel
Frontiers in Immunology13 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossref
Strategic engineering B cell immunity for cancer immunotherapy
Chengyi Li, Hrishi Venkatesh, Lam Trieu +1
Journal of controlled release : official journal of the Controlled Release Society15 Jul 2026Peer-reviewedLicence not statedFull textOncologyPMC
Biomimetic mycobacterial dual spatiotemporal targeting induces trained immunity for tuberculosis photothermal immunotherapy and relapse prevention
Wei Wang, Xiaoxue Li, Meijia Pan +6
eBioMedicine6 Nov 2026Peer-reviewedCC BY-NC-ND 4.0General medicineCrossref
944 Succinate-based metabolic reprogramming of innate and adaptive immunity for ovarian cancer immunotherapy
Remya Raja, Christopher Wu, Marion Curtis +6
Journal for ImmunoTherapy of Cancer6 Nov 2026Peer-reviewedCC BYFull textOncologyDOAJ

Cite

BibTeX

@article{jain20261061,
  title = {{1061 Anchored immunotherapy with CD137 (4-1BB) and CD122 (IL-2/15Rβ) multi-agonists induce monotherapy anti-tumor immunity and abscopal responses without systemic toxicity}},
  author = {Kanika Jain and Sailaja Battula and Robert G Newman and Howard L Kaufman},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.1061},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.1061},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - 1061 Anchored immunotherapy with CD137 (4-1BB) and CD122 (IL-2/15Rβ) multi-agonists induce monotherapy anti-tumor immunity and abscopal responses without systemic toxicity
AU  - Kanika Jain
AU  - Sailaja Battula
AU  - Robert G Newman
AU  - Howard L Kaufman
PY  - 2026
DA  - 2026/11/07
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.1061
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.1061
SN  - 2051-1426
ER  -

Related

Cite